Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6f1c879e3c6a92035fcc6401df5399f6 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_60da379fb33c192ef77f86a60c5ac029 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_002eb438b2cacb0e550dada40741e320 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4178 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4178 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-06 |
filingDate |
2014-03-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_47539cde75c24ebf9694be94519d5520 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5d7e66258e397697a9040b3fecd94f3c |
publicationDate |
2014-09-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
US-2014255517-A1 |
titleOfInvention |
Managing post-traumatic stress disorder |
abstract |
In certain embodiments, the disclosure relates to methods of treating or preventing posttraumatic stress disorder comprising administering a pharmaceutical composition comprising effective amount of an angiotensin-converting enzyme inhibitor to a subject in need thereof. In certain embodiments, the angiotensin-converting enzyme inhibitor is administered in combination with an angiotensin receptor blocker. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2016134215-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11160982-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10105416-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2019009091-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10617740-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11241483-B2 |
priorityDate |
2013-03-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |